EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development and validation of a prediction tool to optimize antenatal corticosteroid timing in patients at risk of spontaneous preterm birth

Moti Gulersen iD, Adam Lin, Ansaf Salleb-Aouissi, Anita Raja, Robert M Silver iD, William A Grobman, Lynn M Yee, Judith H Chung, Hyagriv N Simhan, Ashley N Battarbee, Cynthia Gyamfi-Bannerman, Vincenzo Berghella und 1 weitere

Pregnancy · 2026-01 · 2 (1)

DOI: 10.1002/pmf2.70217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pregnancy, online erschienen am 30.12.2025. Verfasst von Moti Gulersen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine Department of Obstetrics and Gynecology Sidney Kimmel Medical College of Thomas Jefferson University Philadelphia…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The objective of this study was to develop and validate a preterm birth (PTB) prediction model to optimize the timing of antenatal corticosteroid (ACS) administration in patients at risk of spontaneous PTB.

Methods

Secondary analysis of the nuMoM2b (Nulliparous Pregnancy Outcomes Study: Monitoring Mothers‐to‐Be) prospective cohort study including participants who received ACS due to increased risk for spontaneous PTB (i.e., development cohort). Nulliparous participants presenting between 23 0/7 and 36 6/7 weeks of gestation were eligible for inclusion and were characterized into two groups based on the time interval from the first dose of ACS administration to delivery: ≤7 versus >7 days. Multivariable logistic regression was utilized to assess clinical characteristics at the time of the first dose of ACS administration as candidate predictors for optimal ACS timing, defined as delivery within 7 days of ACS administration. We then externally validated the model using data from patients at risk for spontaneous PTB at two academic centers. The predictive performance of each model was assessed using area under the receiver operating curve (ROC AUC), precision, and recall scores with 95% confidence intervals (CIs).

Results

Key predictors for optimal ACS timing were rupture of membranes, cervical dilation and effacement at admission, maternal age, and gravidity. In the development cohort, the model achieved an AUC of 0.84 (95% CI, 0.77–0.92). External validation of these models in two independent cohorts demonstrated consistent performances (AUC, 0.82; 95% CI, 0.75–0.88 and AUC, 0.81; 95% CI, 0.72–0.89).

Conclusion

We successfully developed and externally validated a model that predicts whether nulliparas are expected to deliver within 7 days of ACS administration. Further studies can assess whether incorporating this model into clinical practice improves neonatal outcomes.

Schlagwörter

Stichwörter der Autor:innen

betamethasoneclinical prediction modelprematurityrisk estimationrisk stratification

Autor:innen und Institutionen

  • Division of Maternal-Fetal Medicine Department of Obstetrics and Gynecology Sidney Kimmel Medical College of Thomas Jefferson University Philadelphia Pennsylvania USA.
  • Department of Computer Science Columbia University New York New York USA.
  • Department of Computer Science CUNY Hunter College New York New York USA.
  • Division of Maternal-Fetal Medicine Department of Obstetrics and Gynecology Spencer Fox Eccles School of Medicine at the University of Utah Salt Lake City Utah USA.
  • Division of Maternal-Fetal Medicine Department of Obstetrics and Gynecology Warren Alpert Medical School of Brown University Providence Rhode Island USA.
  • Division of Maternal-Fetal Medicine Department of Obstetrics and Gynecology Northwestern University Feinberg School of Medicine Chicago Illinois USA.

ORCID-Profile: Moti Gulersen, Robert M Silver, David M Haas

Zitieren

APA

Gulersen, M., Lin, A., Salleb-Aouissi, A., Raja, A., Silver, R. M., Grobman, W. A., Yee, L. M., Chung, J. H., Simhan, H. N., Battarbee, A. N., Gyamfi-Bannerman, C., Berghella, V., & Haas, D. M. (2026). Development and validation of a prediction tool to optimize antenatal corticosteroid timing in patients at risk of spontaneous preterm birth. Pregnancy, 2(1). https://doi.org/10.1002/pmf2.70217

Vancouver

Gulersen M, Lin A, Salleb-Aouissi A, Raja A, Silver RM, Grobman WA, et al. Development and validation of a prediction tool to optimize antenatal corticosteroid timing in patients at risk of spontaneous preterm birth. Pregnancy. 2026;2(1). doi:10.1002/pmf2.70217

BibTeX
@article{Gulersen2026,
  author = {Gulersen, Moti and Lin, Adam and Salleb-Aouissi, Ansaf and Raja, Anita and Silver, Robert M and Grobman, William A and Yee, Lynn M and Chung, Judith H and Simhan, Hyagriv N and Battarbee, Ashley N and Gyamfi-Bannerman, Cynthia and Berghella, Vincenzo and Haas, David M},
  title = {Development and validation of a prediction tool to optimize antenatal corticosteroid timing in patients at risk of spontaneous preterm birth},
  journal = {Pregnancy},
  year = {2026},
  volume = {2},
  number = {1},
  doi = {10.1002/pmf2.70217}
}
Kostenlos starten →